Portage Biotech Inc - ESG Rating & Company Profile powered by AI
The analysis of Portage Biotech Inc is assembled by All Street Sevva using proprietary AI. The page is a free Sustainability analysis covering Portage Biotech Inc. Detailed Sustainability assessment of Portage Biotech Inc can be reached by signing in.
Portage Biotech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.6; made up of an environmental score of 4.0, social score of 4.0 and governance score of 5.7.
4.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1156 | Vectus Biosystems Ltd | 4.7 | High |
| 1156 | Zynerba Pharmaceuticals Inc | 4.7 | High |
| 1199 | Portage Biotech Inc | 4.6 | High |
| 1199 | Allergan Inc | 4.6 | High |
| 1199 | AroCell AB (publ) | 4.6 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Portage Biotech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Portage Biotech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Portage Biotech Inc report the average age of the workforce?
Sign up for free to unlockDoes Portage Biotech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Portage Biotech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Portage Biotech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Portage Biotech Inc offer flexible work?
Sign up for free to unlockDoes Portage Biotech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Portage Biotech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Portage Biotech Inc conduct supply chain audits?
Sign up for free to unlockDoes Portage Biotech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Portage Biotech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Portage Biotech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Portage Biotech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Portage Biotech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Portage Biotech Inc disclose water use targets?
Sign up for free to unlockDoes Portage Biotech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Portage Biotech Inc have a product recall in the last two years?
Sign up for free to unlockDoes Portage Biotech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Portage Biotech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Portage Biotech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Portage Biotech Inc disclose parental leave metrics?
Sign up for free to unlockDoes Portage Biotech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Portage Biotech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Portage Biotech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Portage Biotech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Portage Biotech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Portage Biotech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Portage Biotech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Portage Biotech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Portage Biotech Inc disclose its waste policy?
Sign up for free to unlockDoes Portage Biotech Inc report according to TCFD requirements?
Sign up for free to unlockDoes Portage Biotech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Portage Biotech Inc disclose energy use targets?
Sign up for free to unlockDoes Portage Biotech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Portage Biotech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Portage Biotech Inc
These potential risks are based on the size, segment and geographies of the company.
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; TT-10, an adenosine receptor type 2A (A2A) inhibitor to treat A2A expressing solid tumors; TT-4, an adenosine receptor type 2B (A2B) inhibitor to treat solid tumors; TT-53, an A2A/A2B inhibitor to treat solid tumors; TT-3, an A2B inhibitor to treat colorectal and gastrointestinal cancers; and NT230-6 that is in Phase I/II clinical trials for the treatment of tumors. It also provides Nanolipogel (NLG) co-formulation platform for delivery of DNA aptamers and certain aptamer-small molecule-based combination products; and STING agonist platform, a proprietary immune priming and boosting technology, offers various ways to target immune stimulation towards the cancer, as well as to co-deliver various signals in a single product. The company is based in Tortola, British Virgin Islands.